This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Omniox, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kevin G Leong: Innovator in Tumor Immunity Modulation
Introduction
Kevin G Leong is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on enhancing tumor immunity, which is crucial for developing effective cancer therapies.
Latest Patents
Kevin G Leong holds a patent for "Modulation of tumor immunity by protein-mediated Odelivery." This invention provides methods to modulate hypoxia-mediated tumor immunity by administering an Ocarrier polypeptide, such as an H-NOX protein. The methods target both hypoxia-inducible factor 1 alpha (HIF-1α) pathways and non-HIF-1α pathways of tumor immunity. Such methods are useful in treating a wide variety of cancers and may be used alone or in combination with other anti-cancer therapies. He has 1 patent to his name.
Career Highlights
Kevin is associated with Omniox, Inc., where he continues to advance his research in tumor immunity. His work is pivotal in the ongoing quest to improve cancer treatment options and patient outcomes.
Collaborations
Some of his notable coworkers include Stephen P L Cary and Ana Krtolica, who contribute to the innovative environment at Omniox, Inc.
Conclusion
Kevin G Leong's contributions to tumor immunity modulation represent a significant advancement in cancer treatment. His innovative approaches and patented methods hold promise for improving therapeutic strategies against various cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile